APA (7th ed.) Citation

MAG, A., MGE, E., EK, E., EME, M., & M, E. (2026). Repurposing alogliptin for ulcerative colitis: Involvement of MicroRNAs, anti-inflammatory, and barrier-restoring mechanisms. Naunyn-Schmiedeberg's archives of pharmacology, 399(8), 11745. https://doi.org/10.1007/s00210-026-05060-y

Chicago Style (17th ed.) Citation

MAG, Alenezi, Ewees MGE, El-Sayed EK, Morsy EME, and Elbaz M. "Repurposing Alogliptin for Ulcerative Colitis: Involvement of MicroRNAs, Anti-inflammatory, and Barrier-restoring Mechanisms." Naunyn-Schmiedeberg's Archives of Pharmacology 399, no. 8 (2026): 11745. https://doi.org/10.1007/s00210-026-05060-y.

MLA (9th ed.) Citation

MAG, Alenezi, et al. "Repurposing Alogliptin for Ulcerative Colitis: Involvement of MicroRNAs, Anti-inflammatory, and Barrier-restoring Mechanisms." Naunyn-Schmiedeberg's Archives of Pharmacology, vol. 399, no. 8, 2026, p. 11745, https://doi.org/10.1007/s00210-026-05060-y.